Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study

Ole Dyg Pedersen; Bente Brendorp; Lars Køber; Christian Torp-Pedersen

Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study

Ole Dyg Pedersen, Bente Brendorp, Lars Køber, Christian Torp-Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

20 Citationer (Scopus)

Abstract

Udgivelsesdato: null-null

Originalsprog	Engelsk
Tidsskrift	Congestive Heart Failure
Vol/bind	9
Udgave nummer	6
Sider (fra-til)	333-40
Antal sider	7
ISSN	1079-7998
Status	Udgivet - 2003

Bibliografisk note

Keywords: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Function; Denmark; Electrocardiography; Heart Failure; Heart Rate; Humans; Phenethylamines; Prevalence; Prognosis; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left

Citationsformater

Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study. / Pedersen, Ole Dyg; Brendorp, Bente; Køber, Lars ; Torp-Pedersen, Christian.

I: Congestive Heart Failure, Bind 9, Nr. 6, 2003, s. 333-40.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{7dc7c7f0118d11df803f000ea68e967b,

title = "Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study",

abstract = "Atrial fibrillation is a growing health problem and the most common cardiac arrhythmia, affecting 5% of persons above the age of 65 years. The number of hospital discharges for atrial fibrillation has more than doubled in the past decade. It occurs very often in patients with congestive heart failure and the prevalence increases with the severity of the disease. These two conditions seem to be linked together, and congestive heart failure may either be the cause or the consequence of atrial fibrillation. The prognosis of atrial fibrillation is controversial, but studies indicate that atrial fibrillation is a risk factor in congestive heart failure patients. In the last 10-15 years, significant advances in the treatment of heart failure have improved survival, whereas effective management of atrial fibrillation in heart failure patients still awaits similar progress. Empirically, two strategies have evolved for treatment of atrial fibrillation: 1) rhythm control, which means conversion to sinus rhythm and maintenance of sinus rhythm; and 2) rate control, which means reduction of heart rate to an acceptable frequency. It is unknown whether one of these strategies is better than the other. In this review the authors discuss the prevalence, impact, and treatment of atrial fibrillation in heart failure patients.",

author = "Pedersen, {Ole Dyg} and Bente Brendorp and Lars K{\o}ber and Christian Torp-Pedersen",

note = "Keywords: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Function; Denmark; Electrocardiography; Heart Failure; Heart Rate; Humans; Phenethylamines; Prevalence; Prognosis; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left",

year = "2003",

language = "English",

volume = "9",

pages = "333--40",

journal = "Prevention and Management of Congestive Heart Failure",

issn = "1079-7998",

publisher = "Blackwell Publishing",

number = "6",

}

TY - JOUR

T1 - Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study

AU - Pedersen, Ole Dyg

AU - Brendorp, Bente

AU - Køber, Lars

AU - Torp-Pedersen, Christian

N1 - Keywords: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Function; Denmark; Electrocardiography; Heart Failure; Heart Rate; Humans; Phenethylamines; Prevalence; Prognosis; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left

PY - 2003

Y1 - 2003

N2 - Atrial fibrillation is a growing health problem and the most common cardiac arrhythmia, affecting 5% of persons above the age of 65 years. The number of hospital discharges for atrial fibrillation has more than doubled in the past decade. It occurs very often in patients with congestive heart failure and the prevalence increases with the severity of the disease. These two conditions seem to be linked together, and congestive heart failure may either be the cause or the consequence of atrial fibrillation. The prognosis of atrial fibrillation is controversial, but studies indicate that atrial fibrillation is a risk factor in congestive heart failure patients. In the last 10-15 years, significant advances in the treatment of heart failure have improved survival, whereas effective management of atrial fibrillation in heart failure patients still awaits similar progress. Empirically, two strategies have evolved for treatment of atrial fibrillation: 1) rhythm control, which means conversion to sinus rhythm and maintenance of sinus rhythm; and 2) rate control, which means reduction of heart rate to an acceptable frequency. It is unknown whether one of these strategies is better than the other. In this review the authors discuss the prevalence, impact, and treatment of atrial fibrillation in heart failure patients.

AB - Atrial fibrillation is a growing health problem and the most common cardiac arrhythmia, affecting 5% of persons above the age of 65 years. The number of hospital discharges for atrial fibrillation has more than doubled in the past decade. It occurs very often in patients with congestive heart failure and the prevalence increases with the severity of the disease. These two conditions seem to be linked together, and congestive heart failure may either be the cause or the consequence of atrial fibrillation. The prognosis of atrial fibrillation is controversial, but studies indicate that atrial fibrillation is a risk factor in congestive heart failure patients. In the last 10-15 years, significant advances in the treatment of heart failure have improved survival, whereas effective management of atrial fibrillation in heart failure patients still awaits similar progress. Empirically, two strategies have evolved for treatment of atrial fibrillation: 1) rhythm control, which means conversion to sinus rhythm and maintenance of sinus rhythm; and 2) rate control, which means reduction of heart rate to an acceptable frequency. It is unknown whether one of these strategies is better than the other. In this review the authors discuss the prevalence, impact, and treatment of atrial fibrillation in heart failure patients.

M3 - Journal article

C2 - 14688506

VL - 9

SP - 333

EP - 340

JO - Prevention and Management of Congestive Heart Failure

JF - Prevention and Management of Congestive Heart Failure

SN - 1079-7998

IS - 6

ER -